Clinical Trial Update: Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated a quadruple antiemetic combination (aprepitant, olanzapine, palonosetron, and dexamethasone) for preventing chemotherapy-induced nause…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• DEXAMETHASONE (Dexamethasone)
• Palonosetron (palonosetron)
• olanzapine (olanzapine)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2017-03-30